Unique ID issued by UMIN | UMIN000052999 |
---|---|
Receipt number | R000060377 |
Scientific Title | Development of a new oxygen delivery system combining continuous oxygen flow and demand oxygen delivery system: A prospective, single-blind, randomized crossover trial |
Date of disclosure of the study information | 2023/12/15 |
Last modified on | 2025/01/22 08:52:57 |
Development of a new oxygen delivery system combining continuous oxygen flow and demand oxygen delivery system
Development of a new oxygen delivery system combining continuous oxygen flow and demand oxygen delivery system
Development of a new oxygen delivery system combining continuous oxygen flow and demand oxygen delivery system: A prospective, single-blind, randomized crossover trial
New oxygen delivery system combining continuous oxygen flow and demand oxygen delivery system
Japan |
Chronic respiratory disease and interstitial lung disease
Pneumology |
Others
NO
Comparison efficacy of oxygen supply on oxygen saturation during walking between using conventional oxygen delivery methods (continuous oxygen and demand oxygen delivery system) and a new method (combining continuous oxygen flow and demand oxygen delivery system)
Efficacy
Oxygen saturation measured by pulse oximetry during 6-min walk test (assessed every 1 minute).
Dyspnea (modified Borg scale) and pulse rate before and after 6-min walk test
Interventional
Cross-over
Randomized
Individual
Single blind -investigator(s) and assessor(s) are blinded
Active
NO
NO
3
Treatment
Device,equipment |
6MWT with continuous oxygen flow,
Participants conduct three 6MWT: (1) 6MWT with continuous oxygen flow, (2) 6MWT with demand oxygen delivery system, (3) combined continuous flow oxygen and demand oxygen delivery system. The order of 6MWT with three different oxygen delivery methods was randomly defined.
6MWT with demand oxygen delivery system
6MWT with combined continuous flow oxygen and demand oxygen delivery system
20 | years-old | <= |
Not applicable |
Male and Female
1) can give written informed consent
2) diagnosed COPD according to a current guideline by Japanese Respiratory Society
3) prescribed long-term oxygen therapy due to chronic respiratory failure and use ambulatory oxygen (2L or more) in daily activity
1) significant comorbidities that limited walking (i.e., musculoskeletal, cardiovascular or neurological impairment)
2) significant cognitive impairment that affect study
3) acute exacerbation within 4-weeks prior to inclusion of study.
4) unable to measure SpO2 due to peripheral circulatory impairment
30
1st name | Kazuya |
Middle name | |
Last name | Shingai |
Nagasaki University Graduate School
Biomedical Sciences
852-8520
1-7-1, Sakamoto, Nagasaki, Japan
095-819-7963
k.shingai@hotmail.co.jp
1st name | Kazuya |
Middle name | |
Last name | Shingai |
Kirigaoka Tsuda Hospital
Pulmonary Rehabilitation center
802-0052
3-9-20, Kirigaoka, Kokurakita, Kitakyusyu, Fukuoka
093-921-0438
k.shingai@hotmail.co.jp
Nagasaki University
Nagasaki University
Other
Nagasaki University
1-7-1, Sakamoto, Nagasaki, Japan
095-819-7198
gakujutu_gakuji@ml.nagasaki-u.ac.jp
YES
23110904
Nagaski University
霧ヶ丘つだ病院(福岡県)
2023 | Year | 12 | Month | 15 | Day |
Unpublished
29
Completed
2023 | Year | 11 | Month | 29 | Day |
2023 | Year | 11 | Month | 29 | Day |
2023 | Year | 12 | Month | 15 | Day |
2024 | Year | 03 | Month | 31 | Day |
2023 | Year | 12 | Month | 05 | Day |
2025 | Year | 01 | Month | 22 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060377